Diabetes Predicts Liver Graft Failure After Transplant
A study of nearly 2,800 liver transplant recipients links diabetes and functional dependence to graft failure within three years.
Updated on Nov. 9, 2026 in Diabetes

Researchers at Nassau University Medical Center studied nearly 2,800 adult liver transplant recipients transplanted between 2014 and 2024. Diabetes and functional dependence were each associated with higher rates of graft failure, while a body mass index of 35 or higher was not.
Why it matters
The findings suggest that diabetes and patient function, rather than obesity alone, may signal risk for liver transplant failure in patients with metabolic dysfunction-associated steatohepatitis (MASH). Clinicians may use these factors to identify patients who need closer monitoring after transplant.
The study is a retrospective cohort analysis of nearly 2,800 adult liver transplant recipients, with diabetes linked to a hazard ratio of 1.28 and functional dependence to 1.21 for 3-year graft failure. The three-condition combination barely predicted outcomes, and machine-learning models performed only modestly better.
The players
Nassau University Medical Center
A medical center in New York where the lead researcher works, and which is known for its clinical and academic programs in transplant and liver care.
The details
Researchers examined obesity, diabetes, and functional dependence individually and in combination as a metabolic trifecta. Diabetes was also associated with graft failure at one year, and the study tested whether machine learning could improve prediction of graft outcomes.
Timeline
Recipients in the study were transplanted between 2014 and 2024.
Graft failure outcomes were measured three years after transplant.
Diabetes was linked to graft failure at one year after transplant.
Findings were presented on November 9, 2026, at AASLD's The Liver Meeting 2026.
Health Landscape
The findings add to research on metabolic dysfunction-associated steatohepatitis as a leading cause of liver transplant need, a growing area of focus at AASLD's The Liver Meeting. Researchers are now testing whether metabolic risk factors can refine decisions about which transplant recipients require closer follow-up.
Patients with diabetes or limited daily function who are considering liver transplant may face a higher chance of graft failure within three years. Clinicians may use these factors to plan closer follow-up and support after surgery.
The takeaway
Diabetes and reduced daily function may matter more than body weight alone when assessing liver transplant outcomes. Patients with these conditions may benefit from more intensive monitoring after surgery.
Further reading
For more on how metabolic conditions affect long-term health, explore Diabetes coverage on Wisevoter.
Source note: This article includes information reported by Ajmc.



